---
title: LYVA Labs joins iiCON as a core consortium partner
description: LYVA Labs, an innovation investment company based in the Liverpool City Region, has joined the Infection Innovation Consortium (iiCON) as a core consortium partner.
image: https://lyvalabs.com/hubfs/iicon%20Pr%20blog%20thumbnail.png
---

[![logo](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/logo.svg "logo")](https://lyvalabs.com/)

- About 
    - [Our purpose](https://lyvalabs.com/about)
    - [Case studies](https://lyvalabs.com/case-studies)
    - [Team](https://lyvalabs.com/team)
    - [News](https://lyvalabs.com/news)
    - [Annual Report](https://lyvalabs.com/annualreport25-26)
- [Investment](https://lyvalabs.com/investment-fund)
- Programmes 
    - [Adapt](https://lyvalabs.com/adapt)
    - [Incubator](https://lyvalabs.com/incubator)
    - [Accelerate](https://lyvalabs.com/accelerate)
- Services 
    - [Consortia](https://lyvalabs.com/consortia)
- Work with Us 
    - [Careers](https://lyvalabs.com/vacancies)
    - [Consultants](https://lyvalabs.com/lyva-labs-expert-partner-opportunities)

[![logo](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/logo.svg "logo")](https://lyvalabs.com/)

- About 
    - [Our purpose](https://lyvalabs.com/about)
    - [Case studies](https://lyvalabs.com/case-studies)
    - [Team](https://lyvalabs.com/team)
    - [News](https://lyvalabs.com/news)
    - [Annual Report](https://lyvalabs.com/annualreport25-26)
- [Investment](https://lyvalabs.com/investment-fund)
- Programmes 
    - [Adapt](https://lyvalabs.com/adapt)
    - [Incubator](https://lyvalabs.com/incubator)
    - [Accelerate](https://lyvalabs.com/accelerate)
- Services 
    - [Consortia](https://lyvalabs.com/consortia)
- Work with Us 
    - [Careers](https://lyvalabs.com/vacancies)
    - [Consultants](https://lyvalabs.com/lyva-labs-expert-partner-opportunities)

[Contact Us](https://lyvalabs.com/contact)

[Contact Us](https://lyvalabs.com/contact)

 Fri, Feb 13, 2026

# LYVA Labs joins iiCON as a core consortium partner

[LYVA Labs](https://lyvalabs.com/news/author/lyva-labs)

Share: [Share this page on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://lyvalabs.com/news/lyva-labs-joins-iicon) [envelope icon](mailto:?body=https://lyvalabs.com/news/lyva-labs-joins-iicon)

**![iicon Pr blog thumbnail-1](https://lyvalabs.com/hs-fs/hubfs/iicon%20Pr%20blog%20thumbnail-1.png?width=750&height=313&name=iicon%20Pr%20blog%20thumbnail-1.png)**

LYVA Labs has joined the [Infection Innovation Consortium (iiCON)](https://www.infectioninnovation.com/) as a core consortium partner. Led by the [Liverpool School of Tropical Medicine](https://www.lstmed.ac.uk/), iiCON is a global R&D programme that brings together industry, academia, and clinical organisations to speed up the discovery and development of new treatments, diagnostics, and preventative products for infectious diseases — saving and improving millions of lives through collaborative innovation.

LYVA Labs, which launched in 2021, works to drive investment and growth through the commercialisation of innovation. Supported by a £10.5M investment from the Liverpool City Region Combined Authority, LYVA Labs provides funding, incubation, and consultancy to companies at all stages, accelerating and supporting innovation-led growth with a particular focus on organisations working in health, life sciences, and deep tech.

Through this partnership, LYVA Labs joins existing core partners within iiCON including Evotec, Infex Therapeutics, LifeArc, Liverpool University Hospitals Foundation Trust, Medicines for Malaria Venture (MMV), Unilever, and the University of Liverpool.

Under the new agreement, the two organisations will pool knowledge and resources to deliver key programmes of activity to strengthen innovation-led growth across the Liverpool City Region, nationally and globally.

As a core partner, LYVA Labs will strengthen iiCON’s activity to support SMEs and develop regional innovation ecosystems. It will also work to support the spin-out and commercialisation of assets developed by iiCON partners and collaborators.

> Professor Janet Hemingway, iiCON founding director, said:  
> “LYVA Labs has had an incredible impact on the Liverpool City Region since it launched four years ago — playing an important role in expanding and strengthening the regional ecosystem and scaling innovation led activity.
> 
> “iiCON and LYVA Labs have jointly delivered a number of impactful programmes to drive forward innovation led growth over the years and our organisations benefit from significant synergies. Welcoming LYVA Labs as a core member of our consortium formalises this partnership.
> 
> “This agreement will strengthen the existing links between the organisations and enable us to continue to work together to deliver new programmes that will expand and strengthen the innovation ecosystem both in the Liverpool City Region and beyond.”

> Lorna Green, CEO of LYVA Labs, said:  
> “iiCON is an international success, delivering groundbreaking translational research in infectious disease and infection control alongside global pharmaceutical companies and innovative SMEs. We have already worked closely with Janet and the iiCON team to deliver tailored accelerator programmes and secure investment for SMEs developing future therapies and solutions to prevent the spread of infection.
> 
> As a core partner, we’re excited to build on this collaboration, attracting greater private sector investment into the regional economy and supporting more SMEs to grow, scale, and bring impactful innovations to market.”

Founded in 2020 with a £18.6m Strength in Places Fund grant from UK Research and Innovation (UKRI), iiCON has gone on to secure over £251 million in investment. It has created 770 North West jobs and helped to increase the region’s R&D infection spend to over £1 billion since it launched five years ago.

Working with a global network of almost 1,000 organisations, iiCON enables industry access to world-leading infection R&D facilities and expertise. It has supported 36 new products to market, with over 5 billion units of life-saving products and treatments reaching communities across the world.

iiCON is currently developing the Liverpool Robotic Infection Research Laboratory, the UK’s first Category Three Robotic Infection laboratory at the Liverpool School of Tropical Medicine, where new technology is being leveraged to super-charge infection R&D in the Liverpool City Region.

[investment](https://lyvalabs.com/news/tag/investment), [health & life science](https://lyvalabs.com/news/tag/health-life-science), [consortia](https://lyvalabs.com/news/tag/consortia)

## Related posts

[![](https://lyvalabs.com/hs-fs/hubfs/Blog%20Post%20Thumbnail%20for%20Hubspot.png?height=200&name=Blog%20Post%20Thumbnail%20for%20Hubspot.png)](https://lyvalabs.com/news/lyva-labs-to-lead-open-innovation-network-for-commercialising-microbiome-research)

[health & life science](https://lyvalabs.com/news/tag/health-life-science), [microbials](https://lyvalabs.com/news/tag/microbials)

## [LYVA Labs to lead open innovation network for  commercialising microbiome research](https://lyvalabs.com/news/lyva-labs-to-lead-open-innovation-network-for-commercialising-microbiome-research)

[LYVA Labs](https://lyvalabs.com/news/author/lyva-labs) 

 Mon, Nov 18, 2024

[Read more](https://lyvalabs.com/news/lyva-labs-to-lead-open-innovation-network-for-commercialising-microbiome-research)

[![](https://lyvalabs.com/hs-fs/hubfs/IIFPitchday26-80.jpg?height=200&name=IIFPitchday26-80.jpg)](https://lyvalabs.com/news/inside-the-standout-moments-from-lcr-innovation-investment-fortnight-pitch-day-2026)

## [Inside the standout moments from LCR Innovation Investment Fortnight Pitch Day 2026](https://lyvalabs.com/news/inside-the-standout-moments-from-lcr-innovation-investment-fortnight-pitch-day-2026)

[LYVA Labs](https://lyvalabs.com/news/author/lyva-labs) 

 Tue, Jun 16, 2026

[Read more](https://lyvalabs.com/news/inside-the-standout-moments-from-lcr-innovation-investment-fortnight-pitch-day-2026)

[![](https://lyvalabs.com/hs-fs/hubfs/Paul%20Launchpad%20Announcement.png?height=200&name=Paul%20Launchpad%20Announcement.png)](https://lyvalabs.com/news/innovate-uk-advanced-manufacturing)

## [LYVA Labs awarded advanced manufacturing innovation cluster manager role](https://lyvalabs.com/news/innovate-uk-advanced-manufacturing)

[LYVA Labs](https://lyvalabs.com/news/author/lyva-labs) 

 Tue, Feb 14, 2023

We are delighted to announce that we have been awarded the Advanced Manufacturing Innovation...

[Read more](https://lyvalabs.com/news/innovate-uk-advanced-manufacturing)

[![logo-light](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/logo-light.svg "logo-light")](https://lyvalabs.com/)

- [![location](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/location.svg) Central Tech, 31 Russell St, Liverpool, L3 5LJ ![](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/link.svg)](https://maps.app.goo.gl/2UkwzwAXMeanwV4s9)
- ![mail](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/mail.svg) enquiries@lyvalabs.com ![](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/link.svg)
- [![linkedin](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/linkedin.svg) LinkedIn ![](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/link.svg)](https://www.linkedin.com/company/lyvalabs/)

About Us

- [Our purpose](https://lyvalabs.com/about)
- [News](https://lyvalabs.com/news)
- [Case studies](https://lyvalabs.com/case-studies)

Programmes

- [Incubator](https://lyvalabs.com/incubator)
- [Accelerate](https://lyvalabs.com/accelerate)
- [Adapt](https://lyvalabs.com/adapt-waitlist)

Services

- [Investment](https://lyvalabs.com/investment-fund)
- [Consortia](https://lyvalabs.com/consortia)

Keep up to date with LYVA Labs by subscribing to our newsletter.

© 2026 LCR Ventures trading as LYVA Labs. All rights reserved.

- Terms & Conditions
- [Privacy Policy](https://lyvalabs.com/privacy-policy)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "LYVA Labs",
    "url" : "https://lyvalabs.com/news/author/lyva-labs"
  },
  "dateModified" : "2026-04-17T13:27:07.850Z",
  "datePublished" : "2026-02-13T12:27:07.000Z",
  "headline" : "LYVA Labs joins iiCON as a core consortium partner",
  "image" : [ "https://lyvalabs.com/hubfs/iicon%20Pr%20blog%20thumbnail.png" ],
  "mainEntityOfPage" : {
    "@id" : "https://lyvalabs.com/news/lyva-labs-joins-iicon",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://lyvalabs.com/hubfs/LYVA%20Labs%20Logos/Wordmark%20Logo/Wordmark_Black-01.png"
    },
    "name" : "LYVA Labs"
  }
}
```